PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurology, Stony Brook University Medical Center, Stony Brook, NY, USA.\', \'Biogen, Cambridge, MA, USA.\', \'Biogen, Cambridge, MA, USA. megan.vignos@biogen.com.\', \'US Medical MS Franchise and Interferons, Biogen, 133 Boston Post Rd, Weston, MA, 20493, USA. megan.vignos@biogen.com.\', \'Johns Hopkins University School of Medicine, Baltimore, MD, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s12325-021-01761-3
?:doi
?:hasPublicationType
?:journal
  • Advances in therapy
is ?:pmid of
?:pmid
?:pmid
  • 34075554
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.075
?:rankingScore_hIndex
  • 51
is ?:relation_isRelatedTo_publication of
?:title
  • Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34075554>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34075554>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all